News About: Pharm. Industry
Kyung Nam Pharm suspends M&A process for open sale
Kyung Nam Pharm gave a suspension notice of the M&A process for open sale on the 29th. Thus, they will face a new era with the open sale that they have carried out for transparency in managing the company after suspen...
Prosecution’s investigation on Hanjin Group Chairman Yang-Ho Cho for pharmacy rentals
As investigating Hanjin Group Chairman Yang-Ho Cho’s corruptions, such as getting omitted with inheritance taxes, the prosecution is also investing if he ran pharmacy rentals.’
According to a media report on the 29th...
LG Chem starts to aim for rheumatoid arthritis market
LG Chem will start to aim for the Korean rheumatoid arthritis market.
LG Chem announced on the 28th that the company start to sell a rheumatoid arthritis therapy ‘Eucept(generic name: etanercept)’ in Korea.
Eucept, ...
2.7% and 2.1% increases for clinics and dentists, and 3.49% raise for NHIS in 2019
The conversion rates for clinics and dentists got broken down at the recent health care cost negotiation, but they were decided at 2.7% and 2.1% respectively. Thus, the National Health Insurance Service’s increase rat...
What is the most important factor in recruiting new chairman at KPBMA?
The industry has paid attention to recruiting new Chairman of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) which has been vacant for a while.
After former Chariman Hee-Mok Won voluntarily ...
Brinks Global signs MOU with DKSH for drug market
Brinks Global, a secured distribution company for pharmaceutical products and valuables, announced the company signed a memorandum of understanding(MOU) for introduction to the drug market and cooperation in secured d...
Kolon Life Science signs ‘INVOSSA’ export agreement to Saudi Arabia and UAE
Kolon Life Science(CEO Woo-Seok Lee) signed an exclusive sales & export agreement with Mundipharma as a strategic partner to enter Saudi Arabia and the United Arab Emirates(UAE) with ‘INVOSSA®-K,’ the first knee osteo...
2 of 5 listed pharmas are managed by multiple CEOs
2 of 5 listed pharmaceutical companies were reportedly managed by more than 2 CEOs.
It seems the system spreads for the intent of responsibly running a company with separated roles between shareholders and profession...
Merck to focus on cancer immunotherapy, multiple sclerosis and infertility
Merck Korea, a Korean branch of Merch, the global life science company, announced a promise to lead the future industry by focusing on ‘cancer immunotherapy,’ ‘multiple sclerosis’ and ‘infertility’ in the pharmaceutic...
Celltrion Healthcare sells Remsima exclusively in Libya and Tunisia
As winning the bidding competition for infliximab biosimilar in the Middle Eastern countries, Celltrion Healthcare started to exclusively sell ‘Remsima(generic name: infliximab),’ a biosimilar for the treatment of aut...
